Crossmark

Plasma Vanin-1 as a Novel Biomarker of Sepsis for Trauma Patients: A Prospective Multicenter Cohort Study

Published Online: 2021-02-23

Published Print: 2021-06

Authors

Lu, Hongxiang

Zhang, Anqiang

Wen, Dalin

Du, Juan

Sun, Jianhui

Qiao, Liang

Du, Dingyuan

Gu, Wei https://orcid.org/0000-0002-9529-4683
Jiang, Jianxin
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct01713205 at ClinicalTrials.gov

Documents that mention this clinical trial

Plasma Vanin-1 as a Novel Biomarker of Sepsis for Trauma Patients: A Prospective Multicenter Cohort Study
https://doi.org/10.1007/s40121-021-00414-w
Funding

Funding for this research was provided by:

Chongqing Basic Science and Advanced Technology Research Program (cstc2019jcyj-msxmX0266)

National Natural Science Foundation of China (81772061)

National Natural Science Foundation of China (81971830)
License Information

Text and Data Mining valid from 2021-02-23

Version of Record valid from 2021-02-23
More Information

Article History

Received: 17 December 2020

Accepted: 4 February 2021

First Online: 23 February 2021

Document is current